Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321

Falling Comet

Download real time

872.45 3.60 (0.41%)

34.12% Fall from 52W High

443.7K NSE+BSE Volume

NSE 15 Apr, 2025 11:49 AM (IST)

87,788.9

Market Cap

High in industry

0.9

Beta 1Year

Low volatility

US FDA Approval

Zydus Life receives final approval from the US FDA to manufacture Jaythari (Deflazacort) tablets See details

Zydus Lifesciences Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Zydus Lifesciences Ltd. from all sources in a single place.

Is Cadila Healthcare Ltd. worth buying?

834 Votes:

Buy 82.13%

Sell 9.95%

Hold 7.91%

RESEARCH REPORTS

Buy SEE REPORTS >

Accumulate SEE REPORTS >